Ronald Hunt is of Harpoon Therapeutics, Inc.. Currently has a direct ownership of 0 shares of HARP, which is worth approximately $0. The most recent transaction as insider was on Mar 11, 2024, when has been sold 13,224 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

RONALD HUNT Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2024
SELL
Sale (or disposition) back to the issuer
-
13,224 Reduced 100.0%
0 Common Stock
Mar 08 2024
BUY
Grant, award, or other acquisition
-
424 Added 3.11%
13,224 Common Stock
Jan 01 2024
BUY
Grant, award, or other acquisition
-
1,072 Added 7.73%
12,801 Common Stock
Nov 27 2023
BUY
Grant, award, or other acquisition
-
5,000 Added 29.89%
11,729 Common Stock
Oct 01 2023
BUY
Grant, award, or other acquisition
-
3,035 Added 31.08%
6,729 Common Stock
Jul 01 2023
BUY
Grant, award, or other acquisition
-
18,656 Added 33.56%
36,941 Common Stock
Apr 01 2023
BUY
Grant, award, or other acquisition
-
18,285 Added 50.0%
18,285 Common Stock

Also insider at

RLYB
Rallybio Corp Healthcare
ITRM
Iterum Therapeutics plc Healthcare
RH

Ronald Hunt

Dublin 2, L2

Track Institutional and Insider Activities on HARP

Follow Harpoon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HARP shares.

Notify only if

Insider Trading

Get notified when an Harpoon Therapeutics, Inc. insider buys or sells HARP shares.

Notify only if

News

Receive news related to Harpoon Therapeutics, Inc.

Track Activities on HARP